Gastrointestinal complications and extraintestinal manifestations of inflammatory bowel disease in Taiwan: A population-based study

被引:28
|
作者
Hsu, Yung-Cheng [1 ]
Wu, Tzee-Chung [1 ,2 ]
Lo, Yu-Cheng [1 ]
Wang, Li-Shu [1 ]
机构
[1] Taipei Vet Gen Hosp, Childrens Med Ctr, Div Gastroenterol, 201 Sect 2,Shih Pai Rd, Taipei 112, Taiwan
[2] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan
关键词
Crohn's disease; extraintestinal manifestations; inflammatory bowel disease; ulcerative colitis; PYODERMA-GANGRENOSUM; CUTANEOUS MANIFESTATIONS; ULCERATIVE-COLITIS; COLORECTAL-CANCER; ERYTHEMA-NODOSUM; NATURAL-HISTORY; FOLLOW-UP; RISK; PATHOPHYSIOLOGY; EPIDEMIOLOGY;
D O I
10.1016/j.jcma.2016.08.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Despite a rising incidence of inflammatory bowel disease (IBD) in Taiwan, the clinical presentation of TBDs in this population has yet to be well characterized. Therefore, the aim of our study was to identify and describe the clinical features of gastrointestinal (GI) complications and extraintestinal manifestations (EIMs) of IBDs in the Taiwanese population. Methods: We conducted a retrospective study between 1998 and 2011, with relevant medical information extracted from the National Health Insurance Research Database. The diagnoses of IBD, GI complications, and EIMs were defined from the health registry using the appropriate International Classification of Diseases 9 codes. Results: A total of 3153 patients with IBDs were identified: 611 with Crohn's disease (CD) and 2542 with ulcerative colitis, with GI complications and EIMs identified in 22.2% and 11.9% of cases, respectively. CD was associated with an increased incidende of intestinal fistula, perforation, obstruction, peritonitis and perianal disease, and ulcerative colitis with benign neoplasm of the colon. Colorectal cancer developed in 0.35% of patients. Children with CD characteristically have more complex intestinal complications. The prevalence of EIMs was higher in females and in CD, with peripheral arthritis identified as the most common EIMs, overall. The rate of major EIMs affecting the articular, cutaneous, and visual systems was lower than the rate reported in Western countries. Conclusion: Our study found that CD had a more complicated course, with a higher incidence of GI complications and EIMS. However, the prevalence of intestinal complications, perianal disease, and major EIMS was less common than in Western countries. This study provided a distinct clinical feature of IBD in Taiwan. Copyright (C) 2016, the Chinese Medical Association. Published by Elsevier Taiwan LLC.
引用
收藏
页码:56 / 62
页数:7
相关论文
共 50 条
  • [31] Treatment of extraintestinal manifestations in inflammatory bowel disease
    Adrian A. van Bodegraven
    A. Salvador Peña
    Current Treatment Options in Gastroenterology, 2003, 6 (3) : 201 - 212
  • [32] EXTRAINTESTINAL MANIFESTATIONS OF INFLAMMATORY BOWEL-DISEASE
    BOUHNIK, Y
    BENAMOUZIG, R
    RYBOJAD, M
    MATUCHANSKY, C
    RAMBAUD, JC
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1993, 17 (02): : 121 - 129
  • [33] Age at disease onset of inflammatory bowel disease is associated with later extraintestinal manifestations and complications
    Herzog, Denise
    Fournier, Nicolas
    Buehr, Patrick
    Rueger, Vanessa
    Koller, Rebekka
    Heyland, Klaas
    Nydegger, Andreas
    Spalinger, Johannes
    Schibli, Susanne
    Petit, Laetitia-Marie
    Braegger, Christian P.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (06) : 598 - 607
  • [34] Treatment of extraintestinal manifestations of inflammatory bowel disease
    Grand, RJ
    INFLAMMATORY BOWEL DISEASES, 1998, 4 (01) : 72 - 72
  • [35] Treatment of Extraintestinal Manifestations in Inflammatory Bowel Disease
    Lakatos, Peter L.
    Lakatos, Laszlo
    Kiss, Lajos S.
    Peyrin-Biroulet, Laurent
    Schoepfer, Alain
    Vavricka, Stephan
    DIGESTION, 2012, 86 : 28 - 35
  • [36] Extraintestinal manifestations of inflammatory bowel disease.
    Bernstein C.N.
    Current Gastroenterology Reports, 2001, 3 (6) : 477 - 483
  • [37] Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease
    Hanzel, Jurij
    Ma, Christopher
    Vande Casteele, Niels
    Khanna, Reena
    Jairath, Vipul
    Feagan, Brian G.
    DRUGS, 2021, 81 (03) : 333 - 347
  • [38] Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease
    Jurij Hanzel
    Christopher Ma
    Niels Vande Casteele
    Reena Khanna
    Vipul Jairath
    Brian G. Feagan
    Drugs, 2021, 81 : 333 - 347
  • [39] Extraintestinal Manifestations Associated with Inflammatory Bowel Disease
    Brown, Shaun R.
    Coviello, Lisa C.
    SURGICAL CLINICS OF NORTH AMERICA, 2015, 95 (06) : 1245 - +
  • [40] Characterisation of Extraintestinal Manifestations in Inflammatory Bowel Disease, and Chronology of Extraintestinal relative to Intestinal Manifestations in the Swiss Inflammatory Bowel Disease Cohort
    Vavricka, Stephan R.
    Rogler, Gerhard
    Gantenbein, Claudine
    Spoerri, Muriel
    Vavricka, Mareike Prinz
    Navarini, Alexander A.
    French, Lars
    Safroneeva, Ekaterina
    Fournier, Nicolas
    Straumann, Alex
    Froehlich, Florian
    Fried, Michael
    Michetti, Pierre
    Schoepfer, Alain M.
    SWISS MEDICAL WEEKLY, 2013, 143 : 14S - 14S